Graham Capital Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$131K Sell
38,236
-55,222
-59% -$172K ﹤0.01% 1113
2026
Q1
$213K Sell
93,458
-68,838
-42% -$159K 0.01% 935
2025
Q4
$454K Buy
162,296
+36,875
+29% +$132K 0.01% 658
2025
Q3
$602K Buy
125,421
+78,029
+165% +$496K 0.01% 552
2025
Q2
$431K Buy
+47,392
New +$349K 0.01% 881
2024
Q2
Sell
-61,292
Closed -$1.7M 1276
2024
Q1
$1.7M Buy
61,292
+7,446
+14% +$165K 0.03% 283
2023
Q4
$1.04M Buy
53,846
+28,468
+112% +$516K 0.02% 384
2023
Q3
$410K Sell
25,378
-42,887
-63% -$761K 0.01% 622
2023
Q2
$1.3M Sell
68,265
-37,643
-36% -$671K 0.04% 302
2023
Q1
$1.54M Buy
+105,908
New +$1.9M 0.05% 346
2022
Q4
Sell
-46,466
Closed -$1.12M 1254
2022
Q3
$1.12M Buy
+46,466
New +$1.43M 0.04% 438

Other funds holding ACH

Graham Capital Management's ACH Position: Q2 2026 in Review

Graham Capital Management reduced its Accendra Health (ACH) stake by 59% in Q2 2026, selling an estimated $172K and leaving 38,236 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #1113.

Graham Capital Management first reported a position in ACH in Q3 2022 and has held it in 11 quarters since. The position peaked at $1.7M in Q1 2024. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Graham Capital Management held 38,236 shares of Accendra Health worth $131K as of Q2 2026.
  • Graham Capital Management sold 55,222 Accendra Health shares in Q2 2026, an estimated $172K.
  • Accendra Health made up ﹤0.01% of Graham Capital Management's portfolio in Q2 2026, its #1113 holding.
  • Graham Capital Management first reported a position in Accendra Health in Q3 2022 and has held it in 11 quarters since.
  • Graham Capital Management's Accendra Health position peaked at $1.7M in Q1 2024.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.